HOME >> MEDICINE >> NEWS
Life-saving properties of beta blockers extend to more patients

antiarrhythmic drugs in combination with beta blocker therapy compared with antiarrhythmic therapy alone."

This trend was not seen in patients with ICDs, likely reflecting the "significant impact of ICD therapy on sudden cardiac death and the difficulty in further decreasing event rates," they add.

The authors note that patients treated with beta blockers were younger, had higher EF rates, higher rates of recent angina, and more recent heart attacks.

A limitation of the study was the inability to randomize the use of beta blockers because the administration of this therapy was left to the discretion of the referring physicians. Another drawback was that the effects of beta blockers in patients who received antiarrhythmic drugs may be obscured because several of these drugs possess some beta blocker activity.

Even so, the significant decrease in the overall death rate of these high-risk patients taking beta blockers and who hadn't had a recent heart attack combined with previous similar evidence lead the authors' to conclude "it is appropriate to prescribe these drugs in patients with the characteristics of those enrolled in the MUSTT trial."


'"/>

Contact: Carole Bullock
carole.bullock@heart.org
214-706-1279
American Heart Association
28-Oct-2002


Page: 1 2 3

Related medicine news :

1. Life-saving imaging techniques developed at Oxford University
2. Stanford researcher dusts off old drug; uncovers new anti-rejection properties
3. UI-led study shows experimental anti-cancer drug also has anti-HIV properties
4. Secret agents secret revealed - shaken martinis have superior antioxidant properties to those that are stirred
5. Beta-blockers may help broader group of patients with heart problems
6. Beta blockers after cardiac surgery reduce length of stay and complications
7. Beta blockers usage low despite insurance
8. Beta blockers cost effective to society for heart failure treatment
9. Beta-blockers protect brain during bypass surgery
10. Beta-blockers after heart surgery show double benefits
11. Beta-blockers improve outcomes of bypass surgery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Life saving properties beta blockers extend more patients

(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted an ... details the development of RT001, a form of topical botulinum ... trials. For those afraid of needles, the idea of a ... if the drug ultimately gets FDA approval it will be ... , “As the article notes, the size of the ...
(Date:2/27/2015)... 27, 2015 Adding to its ... pharmaceuticals, Benedict Advertising & Marketing has added Sedation ... The company’s patented NITROUSEAL® N20 closed mask and ... of sedation. , Sedation Systems, http://www.sedationsystems.com ... a new level, though it focuses primarily on ...
(Date:2/27/2015)... NY (PRWEB) February 27, 2015 The winter ... mold growth and expansion. When mold grows, it can be ... be sure to avoid the consequences of mold growth with ... Long Island, is offering tips on the best ways to ... wet season, which makes perfect conditions for mold to thrive. ...
(Date:2/27/2015)... Vancouver, BC (PRWEB) February 27, 2015 ... exciting overnight deals for couples who wanted to spend ... with the opportunity to get a jump on Valentine’s ... meal and stay in one of their luxurious rooms. ... on February 13, inviting guests for a mouthwatering 3 ...
(Date:2/27/2015)... Florida Hospital North Pinellas is being ... Gold Plus hospital. In order to receive the award, ... to all Get With The Guidelines - Stroke Quality ... and achieved 75-percent or higher compliance with six of ... These are reporting initiatives to measure quality of care. ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Victorian Hotel Celebrated Valentine’s Day in 2015 With Unique Overnight Deal 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2
(Date:2/27/2015)... Feb. 27, 2015  PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the fourth quarter and full ... was a transformative year for PTC. We are now ... developing RNA-targeted therapies in the rare disease space," stated ... Inc. "We are proud to bring the first treatment ...
(Date:2/27/2015)... 2015  Bionik Laboratories Corp. (OTC:DWTPD), a ... it acquired Bionik Laboratories, Inc., a Toronto ... to qualified accredited investors of units consisting of its ... approximately $6.2 million. Shares of the Company,s common stock ... under the symbol "DWTPD" until FINRA,s approval of the ...
(Date:2/26/2015)... -- RnRMarketResearch.com adds Corneal Ulcers - ... its store. This report p provides an overview ... The report "Corneal Ulcers - Pipeline Review, H2 2014" provides ... Ulcers. Corneal Ulcers are primarily result of the ... & fungal infections. The symptoms of the corneal ...
Breaking Medicine Technology:PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 10PTC Therapeutics Reports Fourth Quarter and 2014 Full Year Financial Results and Provides Corporate Update 11Bionik Laboratories Raises $6.2 Million 2Bionik Laboratories Raises $6.2 Million 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5
Cached News: